Literature DB >> 28454248

Primary bone mantle cell lymphomas with multiple vertebral compression fractures: A case report.

Peng Yang1, Jun Lin1, Hao Liu1, Hao Shen1, Hui-Lin Yang1.   

Abstract

Mantle cell lymphoma (MCL) is a mature B-cell non-Hodgkin lymphoma. Patients with MCL generally present with extensive lymphadenopathy and extranodal involvement. To the best of our knowledge, no cases of primary bone MCL with multiple vertebral compression fractures have been reported in the literature thus far. The current study reports the case of a 75-year-old Chinese male patient presenting with lower back pain for 1 year. B symptoms were not observed in the patient's medical history. X-ray revealed osteoporosis, and mixed osteolytic and osteosclerotic lesions in the T10 and L1 vertebrae with decreased height. Computed tomography of the spine showed multiple vertebral compression fractures, particularly at T10 and L1. Furthermore, magnetic resonance imaging demonstrated a diffuse homogeneous abnormal signal with multiple vertebral compression fractures. The patient underwent vertebral biopsy and percutaneous balloon kyphoplasty. Histopathological examination of the biopsy revealed abnormal, diffuse, atypical, small-sized, slightly irregular lymphocytes with condensed chromatin. Immunohistochemical staining showed CD5+, CD20+ and cyclin D1+. Thus, the patient was diagnosed with primary bone MCLs and chemotherapy was administered. During the 2-month follow-up, the patient remained in a good clinical condition. The present study reports a rare case of primary osseous MCL and a review of the literature.

Entities:  

Keywords:  compression fractures; mantle cell lymphoma; treatment; tumor; vertebrae

Year:  2017        PMID: 28454248      PMCID: PMC5403470          DOI: 10.3892/ol.2017.5553

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  17 in total

1.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data.

Authors:  P M Banks; J Chan; M L Cleary; G Delsol; C De Wolf-Peeters; K Gatter; T M Grogan; N L Harris; P G Isaacson; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-07       Impact factor: 6.394

2.  Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.

Authors:  Lina Nygren; Stefanie Baumgartner Wennerholm; Monika Klimkowska; Birger Christensson; Eva Kimby; Birgitta Sander
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

3.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Adrian Wiestner; Wing C Chan; Joseph M Connors; Elias Campo; Randy D Gascoyne; Thomas M Grogan; H Konrad Muller-Hermelink; Erlend B Smeland; Michael Chiorazzi; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Sarah Henrickson; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Emilio Montserrat; Francesc Bosch; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Richard I Fisher; Thomas P Miller; Michael LeBlanc; German Ott; Stein Kvaloy; Harald Holte; Jan Delabie; Louis M Staudt
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

4.  Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.

Authors:  D D Weisenburger; H Kim; H Rappaport
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

5.  Leukemic involvement is a common feature in mantle cell lymphoma.

Authors:  Ana Ferrer; Itziar Salaverria; Francesc Bosch; Neus Villamor; María Rozman; Silvia Beà; Eva Giné; Armando López-Guillermo; Elías Campo; Emili Montserrat
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

Review 6.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

Review 7.  How I treat mantle cell lymphoma.

Authors:  Michele Ghielmini; Emanuele Zucca
Journal:  Blood       Date:  2009-06-25       Impact factor: 22.113

Review 8.  Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.

Authors:  Julie M Vose
Journal:  Am J Hematol       Date:  2013-12       Impact factor: 10.047

Review 9.  Management of mantle cell lymphoma in the elderly patient.

Authors:  Jeanette K Doorduijn; Hanneke C Kluin-Nelemans
Journal:  Clin Interv Aging       Date:  2013-09-16       Impact factor: 4.458

10.  Mantle cell lymphoma mimicking rectal carcinoma.

Authors:  Engin Kelkitli; Hilmi Atay; Levent Yıldız; Ahmet Bektaş; Mehmet Turgut
Journal:  Case Rep Hematol       Date:  2014-04-17
View more
  3 in total

1.  Bulky primary tibia mantle cell lymphoma achieved complete remission with CHOP and DHAP plus rituximab: A case report.

Authors:  Si Chen; Meng Ye
Journal:  Oncol Lett       Date:  2018-08-29       Impact factor: 2.967

2.  Analyses of the efficacy of percutaneous kyphoplasty and alendronate sodium on thoracolumbar vertebral fracture and the risk factors of fracture.

Authors:  Pengbin Li; Wenjuan Tang; Biao Che; Kai Wang; Kai Zou; Zheng Jin; Feng Zhou; Yan Zhuang
Journal:  Exp Ther Med       Date:  2018-06-01       Impact factor: 2.447

3.  Extremely Rare Primary Spinal Epidural Indolent Mantle Cell Lymphoma: A Case Report With Literature Review.

Authors:  Rohit Prasad; Nishan B Pokhrel; Sushil Paudel; Dinesh Kafle; Rohit K Pokharel
Journal:  Cureus       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.